Catalent Biologics (Catalent), a global contract development and manufacturing organization (CDMO), is a leader in providing comprehensive solutions for life sciences companies of all sizes. Catalent’s 19,000+ employees and approximately 2,500 scientists partner with pharma, biotech, and consumer health companies to optimize product development, launch, and full life-cycle supply for patients around the world.
A seasoned professional with more than 27 years’ experience leading GMP quality assurance, quality control, validation, and manufacturing operations in pharma and related regulated industries, Matthew has been appointed to oversee its global quality assurance and quality control organization.
Three leaders of premiere Maryland educational institutions (two in Baltimore, one south of DC) join an ex-IBM executive and consultancy president to lead the State of Maryland-connected funding entity TEDCO’s board of directors.
TEDCO announced its latest slate of board officers earlier this week, following a virtual election that took place at TEDCO’s Sept. 15 board meeting — the same date the new officers’ tenure took effect.
A statement noted that Omar S. Muhammad, the director of Morgan State University’s Entrepreneurial Development and Assistance Center, will return to chair the board for a second year. His election last year made him the first Black professional to lead TEDCO’s board in its near-quarter-century of existence.
David is an experienced and dependable mechanical engineer with a keen understanding of HVAC&R and mechanical utility system design. He has successfully completed projects for cGMP manufacturing facilities, laboratories, and central utility plants ranging in scope from small-scale renovations below $50k to advanced facility designs exceeding $250 million.
American Gene Technologies, a clinical-stage biotechnology company based in Rockville, Maryland, has promoted Barry H. Wells, M.D. as head of business development. Dr. Wells joined the company’s investor relations team in 2019.
Prince William County Department of Economic Development (PWCDED) hired Helena Kondow-McConaghy, Ph.D. as Business Development Manager for the Life Sciences to recruit and retain businesses in the fastest growing biotechnology cluster in the Greater Washington, D.C. region.
President Joe Biden on Monday appointed longtime biologist and former government scientist Renee Wegrzyn as the first director of the nascent Advanced Research Projects Agency for Health.
Biden’s announcement comes as ARPA-H advocates debate where the multibillion-dollar agency should be headquartered and which elusive disease areas should be prioritized. The president officially launched the agency in March with $1 billion in initial funding allotted by Congress, but the search for its inaugural director has taken months.
Wegrzyn, 45, currently works at Boston-based Ginkgo Bioworks, a company focused on biological engineering, but has prior experience in two government agencies Biden has said he hopes to emulate with ARPA-H — the Pentagon’s Defense Advanced Research Projects Agency and the Intelligence Advanced Research Projects Activity.
Malone is the Managing Director of Early Charm and the CEO of SilcsBio, one of the 37 portfolio companies that operate under Early Charm’s novel Venture Studio Model. We recently caught up with Malone to discuss a wide range of topics, including the Venture Studio Model, SilcsBio, and the growing life sciences and technology ecosystem blooming in Baltimore.
Deka Biosciences (“Deka”), a biotech company focused on the development of novel cytokine therapies to treat cancer and inflammatory diseases, announced today the appointment of Charlotte Moser, MD, PhD, MSc, MBA as Chief Medical Officer (CMO) and Deb Kientop, MBA as Vice President, Clinical Operations.
Zephyr AI, Inc. (“Zephyr AI”), a high-growth healthcare technology company committed to radically reshaping traditional approaches to drug discovery precision medicine and predictive analytics has announced the appointment of Allen Hodge as Chief Commercial Officer. Hodge brings more than two decades of experience in building commercial organizations to this role. Prior to joining Zephyr AI, Hodge served as Senior Vice President and U.S. General Manager at BioCryst Pharmaceuticals, delivering a successful launch of Orladeyo for patients with hereditary angioedema.